INSIGHTS ON CLINICAL TRIAL DESIGN

• Transforming Ophthalmic Assessments For A Mid-Trial Protocol Change

  Discover how a biopharmaceutical company integrated urgent mid-trial mandates across 65 sites, cutting standard onboarding timelines in half while preserving critical enrollment milestones.

• Inclusive Trial Design A 'Must-Have' In Modern R&D

  Inclusivity in trial design is a crucial aspect of the R&D process, recognized for its importance to ensuring scientific validity, ethical responsibility, and public health.

• Accelerated Recruitment Through AI-Powered Patient Matching At Network Scale

  In this Clinical Leader Smart Sourcing session, explore how one how you can improve screening efficiency, reduce false positives, and accelerate trial recruitment with the right partner.

• Redefining Accessibility For Pediatric Patients

  Explore how meeting patients where they are can redefine what successful pediatric trial delivery looks like.

• Disclosure Management System: Build Or Buy?

  6/19/2025

  Clinical trial disclosure regulations are tightening worldwide. In order to maintain compliance, sponsors must determine whether to build an internal disclosure management system or buy a solution.

• Five Integration Pillars To Redefine Frontline Patient Engagement And Safety Operations

  8/20/2026

  Siloed medical information, patient support, product quality, and pharmacovigilance functions, alongside increasing biopharmaceutical complexity, require a unified operating model to meet modern demand.

• Demonstrating IDS Value With Time-Based Metrics

  6/10/2026

  Explore how leading IDS pharmacies are using remote monitoring workflows and digital accountability systems to improve accuracy, reduce site burden, and maintain audit readiness.

• How Community-Based Research Models Expand Access

  9/9/2025

  As momentum continues to grow in neurology research, how can community-based research models help overcome recruitment and retention challenges in complex areas like Alzheimer's?

• Navigating The Challenges Of Large, International Phase III Breast Cancer Trials

  5/27/2026

  In the competitive landscape of breast cancer research, aligning biomarker testing, regulatory pathways, and regional operations from day one creates a path to faster enrollment and stronger outcomes.